Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-Up

BACKGROUND: Human papillomavirus-positive oropharyngeal carcinoma (HPVOPC) portends a more favorable prognosis compared to environmentally related oropharynx cancer (EROPC). Patients with HPVOPC may be overtreated and endure unnecessary long-term toxicities. METHODS: Patients with untreated locally...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Mai, Hwang, Michael, Misiukiewicz, Krysztof, Gupta, Vishal, Miles, Brett A., Bakst, Richard, Genden, Eric, Selkridge, Isaiah, Botzler, John, Virani, Vruti, Moshier, Erin, Bonomi, Marcelo R., Posner, Marshall R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024140/
https://www.ncbi.nlm.nih.gov/pubmed/35463348
http://dx.doi.org/10.3389/fonc.2022.859992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024140/
https://www.ncbi.nlm.nih.gov/pubmed/35463348
http://dx.doi.org/10.3389/fonc.2022.859992

Ejemplares similares